IDWeek 2019 | Events

Join us at IDWeek 2019

October 2-6, 2019    |    Washington, DC    |    Booth 1237

Experience the technology through our interactive demonstration and learn about the reporting features of Accelerate Pheno™ system. See the instrument and user interface in action and schedule a one-on-one meeting with key team members.

IDWeek 2019
Dates: October 2-6, 2019

Location: Walter E. Washington Convention Center, Washington, DC
Booth:  1237

Event Website: IDWeek

Learn more about the Accelerate Pheno™ system

Achieving Rapid Phenotypic Susceptibility Implementation: Framework Perspectives from the Micro Lab and Antimicrobial Stewardship

Exhibit Hall, Learning Lounge 2




Thursday, October 3, 2019 at 1:15 pm


1:20 – 1:35 pm

Presented by: Kimberle Chapin, MD
Director of Microbiology
Lifespan Academic Medical Center, Providence, RI
Professor of Pathology and Laboratory Medicine, Professor of Medicine
Brown University, Providence, RI

1:35 – 1:50 pm

Presented by: Diane Parente, PharmD
Clinical Pharmacist Specialist, Infectious Diseases and Antimicrobial Stewardship
Lifespan Academic Medical Center, Providence, RI

Abstracts and Presentations

Thursday, Oct 3, 12:15-1:30 p.m.

640 – Randomized Clinical Trial Evaluating Clinical Impact of RAPid IDentification and Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia (RAPIDS-GN)

Presented by: Ritu Banerjee, MD, PhD – Associate Professor, Vanderbilt University Medical Center, Nashville, TN


Saturday, Oct. 5, 12:15-1:30 p.m.

2137 – Impact of Accelerate Pheno™ Rapid Blood Culture Detection System with Real Time Notification versus Standard Antibiotic Stewardship on Clinical Outcomes in Bacteremic Patients

Presented by: Courtney Pearson, MD – University of Arkansas for Medical Sciences


1997 – Real-World Impact of Accelerate Pheno Implementation with Antimicrobial Stewardship Intervention

Presented by: Patrick Kinn, PharmD, MPH – Clinical Pharmacy Specialist – Infectious Disease, University of Iowa Hospitals and Clinics, Iowa city, IA


2144 – Performance of 2019 CLSI Ciprofloxacin Breakpoint Antimicrobial Susceptibility Testing Algorithms for Enterobacteriaceae and Pseudomonas aeruginosa Directly from Positive Blood Culture on the Accelerate Pheno™ System

Presented by: Alena Shamsheyeva – Software Engineer, Accelerate Diagnostics, Inc., Tucson, AZ


2290 – Carbapenem versus Piperacillin-Tazobactam Definitive Therapy for Patients with Bloodstream Infections Due to Ceftriaxone Not Susceptible Escherichia coli or Klebsiella species

Presented by: Shawn MacVane, PharmD  – Director, Clinical Studies, Accelerate Diagnostics, Inc., Tucson, AZ


Recent Publications

May 16, 2019

Clinical impact of rapid species identification from positive blood cultures with same-day phenotypic antimicrobial susceptibility testing on the management and outcome of bloodstream infections
Clinical Infectious Diseases

Apr 26, 2019

Integration of a New Diagnostic Test with Antimicrobial Stewardship in a Community Hospital
SHEA 2019

Apr 16, 2019

Impact of Rapid Identification (ID) and Antimicrobial Susceptibility Testing (AST) on Antibiotic Therapy and Outcomes for Patients with Bacteraemia/Candidaemia

See all publications

Learn about our


What it’s like

Inside Accelerate